vs
Side-by-side financial comparison of ROCKWELL MEDICAL, INC. (RMTI) and SOLAI Ltd (SLAI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $11.0M, roughly 1.7× SOLAI Ltd). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -126.2%, a 123.2% gap on every dollar of revenue. On growth, ROCKWELL MEDICAL, INC. posted the faster year-over-year revenue change (-25.6% vs -43.1%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-17.0M).
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
RMTI vs SLAI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.3M | $11.0M |
| Net Profit | $-554.0K | $-13.9M |
| Gross Margin | 21.1% | 0.1% |
| Operating Margin | -2.2% | -126.2% |
| Net Margin | -3.0% | -126.2% |
| Revenue YoY | -25.6% | -43.1% |
| Net Profit YoY | 26.7% | -173.4% |
| EPS (diluted) | $-0.01 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.3M | — | ||
| Q3 25 | $15.9M | — | ||
| Q2 25 | $16.1M | $11.0M | ||
| Q1 25 | $18.9M | — | ||
| Q4 24 | $24.7M | — | ||
| Q3 24 | $28.3M | — | ||
| Q2 24 | $25.8M | $19.4M | ||
| Q1 24 | $22.7M | — |
| Q4 25 | $-554.0K | — | ||
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-1.5M | $-13.9M | ||
| Q1 25 | $-1.5M | — | ||
| Q4 24 | $-756.0K | — | ||
| Q3 24 | $1.7M | — | ||
| Q2 24 | $343.0K | $18.9M | ||
| Q1 24 | $-1.7M | — |
| Q4 25 | 21.1% | — | ||
| Q3 25 | 14.3% | — | ||
| Q2 25 | 15.6% | 0.1% | ||
| Q1 25 | 16.1% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 22.0% | — | ||
| Q2 24 | 17.6% | 52.4% | ||
| Q1 24 | 13.5% | — |
| Q4 25 | -2.2% | — | ||
| Q3 25 | -9.9% | — | ||
| Q2 25 | -8.4% | -126.2% | ||
| Q1 25 | -7.2% | — | ||
| Q4 24 | -2.1% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 2.0% | -2.6% | ||
| Q1 24 | -5.8% | — |
| Q4 25 | -3.0% | — | ||
| Q3 25 | -11.0% | — | ||
| Q2 25 | -9.3% | -126.2% | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -3.1% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 1.3% | 97.9% | ||
| Q1 24 | -7.6% | — |
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $-0.05 | — | ||
| Q2 25 | $-0.05 | $-0.01 | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $0.04 | — | ||
| Q2 24 | $0.01 | $0.02 | ||
| Q1 24 | $-0.06 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.7M | $1.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $37.0M | $43.8M |
| Total Assets | $57.1M | $69.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.7M | — | ||
| Q3 25 | $13.6M | — | ||
| Q2 25 | $12.5M | $1.2M | ||
| Q1 25 | $11.4M | — | ||
| Q4 24 | $15.7M | — | ||
| Q3 24 | $12.3M | — | ||
| Q2 24 | $11.9M | $2.3M | ||
| Q1 24 | $6.6M | — |
| Q4 25 | $37.0M | — | ||
| Q3 25 | $37.0M | — | ||
| Q2 25 | $30.4M | $43.8M | ||
| Q1 25 | $31.5M | — | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $29.1M | — | ||
| Q2 24 | $23.5M | $45.9M | ||
| Q1 24 | $20.6M | — |
| Q4 25 | $57.1M | — | ||
| Q3 25 | $57.5M | — | ||
| Q2 25 | $52.6M | $69.1M | ||
| Q1 25 | $54.0M | — | ||
| Q4 24 | $59.2M | — | ||
| Q3 24 | $57.1M | — | ||
| Q2 24 | $53.0M | $63.3M | ||
| Q1 24 | $50.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-17.0M |
| Free Cash FlowOCF − Capex | $2.2M | $-17.0M |
| FCF MarginFCF / Revenue | 12.0% | -154.2% |
| Capex IntensityCapex / Revenue | 0.5% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | — | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | $1.8M | $-17.0M | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $865.0K | — | ||
| Q3 24 | $4.3M | — | ||
| Q2 24 | $1.4M | $-12.1M | ||
| Q1 24 | $-2.4M | — |
| Q4 25 | $2.2M | — | ||
| Q3 25 | $-1.5M | — | ||
| Q2 25 | $1.7M | $-17.0M | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $470.0K | — | ||
| Q3 24 | $4.1M | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $-2.5M | — |
| Q4 25 | 12.0% | — | ||
| Q3 25 | -9.6% | — | ||
| Q2 25 | 10.5% | -154.2% | ||
| Q1 25 | -18.8% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 4.5% | — | ||
| Q1 24 | -11.1% | — |
| Q4 25 | 0.5% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.0% | 0.0% | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 4.20× | -0.64× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
SLAI
| Data center | $6.5M | 59% |
| Cryptocurrency mining | $4.6M | 41% |
